Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F E Barth

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Blood Cancer Journal|August 23, 2014
KIT mutations in primary mediastinal B-cell lymphomaP D Nagel, A Stenzinger, F M Feld, et al.
Der Pathologe|November 27, 2012
[Round robin test for detection of genomic aberrations in non-Hodgkin lymphoma by in situ hybridization]T F E Barth, L Floßbach, H-W Bernd, et al.
Leukemia|February 18, 2015
Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphomaH Horn, M Ziepert, M Wartenberg, et al.
ESMO Open|July 8, 2025
CDK4/6 inhibition in advanced chordoma: final results of the NCT PMO-1601 trialM-V Teleanu, C E Heilig, S Pirmann, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Blood Cancer Journal|August 23, 2014
KIT mutations in primary mediastinal B-cell lymphomaP D Nagel, A Stenzinger, F M Feld, et al.
Der Pathologe|November 27, 2012
[Round robin test for detection of genomic aberrations in non-Hodgkin lymphoma by in situ hybridization]T F E Barth, L Floßbach, H-W Bernd, et al.
Leukemia|February 18, 2015
Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphomaH Horn, M Ziepert, M Wartenberg, et al.
ESMO Open|July 8, 2025
CDK4/6 inhibition in advanced chordoma: final results of the NCT PMO-1601 trialM-V Teleanu, C E Heilig, S Pirmann, et al.
Pageof 4